BRPI0509068A - métodos para determinar quantitativamente heparinas de constituição especìfica ou heparinas de baixo peso molecular usando hplc - Google Patents
métodos para determinar quantitativamente heparinas de constituição especìfica ou heparinas de baixo peso molecular usando hplcInfo
- Publication number
- BRPI0509068A BRPI0509068A BRPI0509068-7A BRPI0509068A BRPI0509068A BR PI0509068 A BRPI0509068 A BR PI0509068A BR PI0509068 A BRPI0509068 A BR PI0509068A BR PI0509068 A BRPI0509068 A BR PI0509068A
- Authority
- BR
- Brazil
- Prior art keywords
- heparins
- molecular weight
- low molecular
- hplc
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
- C08B37/0078—Degradation products
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
MéTODOS PARA DETERMINAR QUANTITATIVAMENTE HEPARINAS DE CONSTITUIçãO ESPECìFICA OU HEPARINAS DE BAIXO PESO MOLECULAR USANDO HPLC. Método para analisar heparinas ou heparinas de baixo peso molecular caracterizado pelo fato de que a amostra a ser ensaiada é despolimerizada pela ação de heparinases e, então, se apropriado, o despolimerizado obtido é reduzido e então uma análise é efetuada por cromatografia líquida de alto desempenho.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04290790A EP1580197A1 (en) | 2004-03-24 | 2004-03-24 | Method for quantitatively determining specific groups constituting heparins or low molecular wieght heparins using HPLC |
PCT/EP2005/003720 WO2005090409A1 (en) | 2004-03-24 | 2005-03-22 | Method for quantitatively determining specific constituting heparins or low molecular weight heparins using hplc |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI0509068A true BRPI0509068A (pt) | 2007-08-21 |
BRPI0509068B1 BRPI0509068B1 (pt) | 2015-11-03 |
Family
ID=34854727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0509068A BRPI0509068B1 (pt) | 2004-03-24 | 2005-03-22 | método para quantificar a quantidade de componentes em uma amostra de material selecionado de heparinas não fracionadas e heparinas fracionadas |
Country Status (14)
Country | Link |
---|---|
EP (2) | EP1580197A1 (pt) |
JP (1) | JP2007530932A (pt) |
KR (1) | KR20060132741A (pt) |
CN (1) | CN1934135A (pt) |
AR (1) | AR048113A1 (pt) |
AU (1) | AU2005223360A1 (pt) |
BR (1) | BRPI0509068B1 (pt) |
CA (1) | CA2558563A1 (pt) |
IL (1) | IL177604A0 (pt) |
MA (1) | MA28483B1 (pt) |
NO (1) | NO20064809L (pt) |
RU (1) | RU2006137370A (pt) |
WO (1) | WO2005090409A1 (pt) |
ZA (1) | ZA200606730B (pt) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2402753A1 (en) | 2002-03-11 | 2012-01-04 | Momenta Pharmaceuticals, Inc. | Analysis of sulfated polysaccharides |
US8101733B1 (en) | 2006-06-27 | 2012-01-24 | Momenta Pharmaceuticals, Inc. | Methods of evaluating mixtures of polysaccharides |
US7790466B1 (en) | 2007-01-26 | 2010-09-07 | Momenta Pharmaceuticals, Inc. | Evaluating mixtures of low molecular weight heparins by chain profiles or chain mapping |
US7968082B1 (en) | 2007-01-26 | 2011-06-28 | Momenta Pharmaceuticals, Inc. | Evaluating mixtures of low molecular weight heparins by NMR |
US9139876B1 (en) | 2007-05-03 | 2015-09-22 | Momenta Pharmacueticals, Inc. | Method of analyzing a preparation of a low molecular weight heparin |
EP2256139A1 (en) * | 2009-05-05 | 2010-12-01 | Sanofi-Aventis | Novel sulfated heptasaccharide and its use as antithrombotic agent |
EP2256138A1 (en) * | 2009-05-05 | 2010-12-01 | Sanofi-Aventis | Novel acylated 1,6-anhhydro decasaccharide and its use as antithrombotic agent |
EP2256137A1 (en) * | 2009-05-05 | 2010-12-01 | Sanofi-Aventis | Novel sulfated octasaccharide and its use as antithrombotic agent |
EP2256136A1 (en) * | 2009-05-05 | 2010-12-01 | Sanofi-Aventis | Novel acylated decasaccharides and their use as antithrombotic agents |
ES2817779T3 (es) | 2010-01-19 | 2021-04-08 | Momenta Pharmaceuticals Inc | Evaluación de preparaciones de heparina |
UA112070C2 (uk) * | 2011-01-28 | 2016-07-25 | Хангжоу Джіуюан Джін Енджініерінг Ко., Лтд | Спосіб капілярного електрофорезу для аналізу тонкої структури еноксапарину натрію |
WO2012115952A1 (en) | 2011-02-21 | 2012-08-30 | Momenta Pharmaceuticals, Inc. | Evaluating heparin preparations |
CN102206690A (zh) * | 2011-03-13 | 2011-10-05 | 广元市海鹏生物科技有限公司 | 一种肝素寡糖的制备方法 |
CN102323355B (zh) * | 2011-08-22 | 2013-10-16 | 深圳市天道医药有限公司 | 一种酶解-hplc法检测依诺肝素的方法 |
CN102533906B (zh) * | 2012-03-12 | 2013-11-13 | 南京健友生化制药股份有限公司 | 一种依诺肝素钠酶解方法 |
CN103149198B (zh) * | 2013-02-08 | 2015-04-22 | 浙江工业大学 | 一种酶法快速定量检测heparosan的方法 |
CN103755823B (zh) * | 2013-12-12 | 2016-09-28 | 中国海洋大学 | 一种硫酸软骨素中硫酸角质素的纯化与检测方法 |
CN104193849B (zh) * | 2014-08-13 | 2016-08-17 | 南京健友生化制药股份有限公司 | 一种依诺肝素钠的生产方法 |
CN105891343B (zh) * | 2014-12-06 | 2019-01-08 | 烟台东诚药业集团股份有限公司 | 一种舒洛地特组分精细结构分析检测方法 |
CN104483418B (zh) * | 2014-12-30 | 2016-09-14 | 深圳市天道医药有限公司 | 一种rp-ip-hplc法收集依诺肝素寡糖的方法 |
CN104792896A (zh) * | 2015-04-23 | 2015-07-22 | 苏州融析生物科技有限公司 | 一种可彻底特异性酶解依诺肝素钠的肝素酶组合物及其应用 |
CN112005110B (zh) * | 2018-07-24 | 2022-11-29 | 深圳市海普瑞药业集团股份有限公司 | 一种达肝素钠亚硝酸降解产物的分析方法及其应用 |
CN112626058B (zh) * | 2020-12-22 | 2022-09-27 | 山东大学 | 一种外切型肝素酶及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2560995A (en) * | 1994-06-06 | 1996-01-04 | Per Bjorn Ostergaard | A pharmaceutical composition comprising oligosaccharides binding to lipoprotein lipase |
FR2800074B1 (fr) * | 1999-10-22 | 2001-12-21 | Aventis Pharma Sa | Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant |
-
2004
- 2004-03-24 EP EP04290790A patent/EP1580197A1/en not_active Ceased
-
2005
- 2005-03-22 JP JP2007504380A patent/JP2007530932A/ja not_active Withdrawn
- 2005-03-22 RU RU2006137370/04A patent/RU2006137370A/ru not_active Application Discontinuation
- 2005-03-22 AR ARP050101122A patent/AR048113A1/es not_active Application Discontinuation
- 2005-03-22 WO PCT/EP2005/003720 patent/WO2005090409A1/en active Application Filing
- 2005-03-22 AU AU2005223360A patent/AU2005223360A1/en not_active Abandoned
- 2005-03-22 ZA ZA200606730A patent/ZA200606730B/xx unknown
- 2005-03-22 CN CNA2005800094440A patent/CN1934135A/zh active Pending
- 2005-03-22 BR BRPI0509068A patent/BRPI0509068B1/pt not_active IP Right Cessation
- 2005-03-22 EP EP05731429.6A patent/EP1730200B1/en active Active
- 2005-03-22 KR KR1020067019528A patent/KR20060132741A/ko not_active Application Discontinuation
- 2005-03-22 CA CA002558563A patent/CA2558563A1/en not_active Abandoned
-
2006
- 2006-08-21 IL IL177604A patent/IL177604A0/en unknown
- 2006-09-22 MA MA29338A patent/MA28483B1/fr unknown
- 2006-10-23 NO NO20064809A patent/NO20064809L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1730200B1 (en) | 2014-04-23 |
AR048113A1 (es) | 2006-03-29 |
NO20064809L (no) | 2006-10-23 |
RU2006137370A (ru) | 2008-04-27 |
EP1730200A1 (en) | 2006-12-13 |
CA2558563A1 (en) | 2005-09-29 |
MA28483B1 (fr) | 2007-03-01 |
JP2007530932A (ja) | 2007-11-01 |
ZA200606730B (en) | 2008-01-30 |
CN1934135A (zh) | 2007-03-21 |
KR20060132741A (ko) | 2006-12-21 |
WO2005090409A1 (en) | 2005-09-29 |
BRPI0509068B1 (pt) | 2015-11-03 |
AU2005223360A1 (en) | 2005-09-29 |
IL177604A0 (en) | 2006-12-10 |
EP1580197A1 (en) | 2005-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0509068A (pt) | métodos para determinar quantitativamente heparinas de constituição especìfica ou heparinas de baixo peso molecular usando hplc | |
MY145833A (en) | Micro-hydrocarbon analysis | |
van Nuijs et al. | Optimization, validation, and the application of liquid chromatography‐tandem mass spectrometry for the analysis of new drugs of abuse in wastewater | |
BRPI0906903B8 (pt) | anticorpo monoclonal e método de detecção da expressão de cd70 | |
BRPI0614151A2 (pt) | métodos para determinar quais os membros, individualmente ou em combinação, de um conjunto elementar de testes intermediários são preditivos de um conjunto elementar de resultados de teste de uso final, para prever se uma amostra candidato atenderá ao conjunto elementar de resultados de teste de uso final, para prever se uma amostra de lubrificante candidato será aprovada em um teste de uso final escolhido para lubrificantes, para determinar qual a combinação de membros de um conjunto elementar de testes intermediários que tem uma correlação elevada com um conjunto elementar de resultados de teste de uso final e para escolher componentes e quantidades de componentes em lubrificantes, fluidos funcionais ou graxas | |
BRPI0615997A8 (pt) | método para prever a sensibilidade de uma amostra de célula ou tecido, método para induzir apoptose em uma amostra de célula ou tecido e método de tratamento de uma disfunção | |
DK1668368T3 (da) | Detektion af histon-modifikation i cellefrie nukleosomer | |
BRPI0613478B8 (pt) | dispositivo para análise quantitativa de um perfil de metabólito | |
BRPI0512281A (pt) | análise dimensional de conjugados de sacarìdeo com gpc & sec-mals | |
BRPI0607222A2 (pt) | estimativa de ruìdo em uma freqüência por amostragem de ruìdo em outras freqüências | |
SE0303249D0 (sv) | Hematocrit and analyte concentration determination | |
HRP20050273A2 (en) | Method of determining specific groups forming heparins | |
BRPI0605166A (pt) | método de determinação de ácido metilmalÈnico baseado na extração alquilativa associada à cromatografia lìquida acoplada à espectrometria de massas | |
Schettgen et al. | Simultaneous quantification of haemoglobin adducts of ethylene oxide, propylene oxide, acrylonitrile, acrylamide and glycidamide in human blood by isotope-dilution GC/NCI-MS/MS | |
NO20070875L (no) | Apparatkomponenter og fremgangsmater for a anvende disse for a detektere tilstedevaerelsen av et analytt | |
DK2118666T3 (da) | Fremgangsmåde til normalisering af koncentrationen af analytter i en urinprøve | |
BRPI0722361B8 (pt) | métodos para avaliar a concentração de um fármaco imunossupressor em uma amostra de sangue humano, composição de reagente de extração e kit de teste | |
BRPI0400082A (pt) | Método analìtico para a detecção e quantificação de aditivos de combustìvel | |
TW200745551A (en) | Device and methods for detecting and quantifying one or more target agents | |
BRPI0618435A2 (pt) | composição reagente de sensor teste tendo polìmeros de celulose adaptada para auxiliar na determinação de uma concentração de analito de uma amostra fluida, bem como processo de determinação de uma concentração de analito de uma amostra fluida | |
NO20083133L (no) | Dobbel transdermal analyttsensorsammensetning samt metoder for anvendelse derav | |
DE602005013430D1 (de) | Verwendung von asc als marker für kolorektalkarzinome | |
AR041320A1 (es) | Metodo de determinacion de agrupamientos especificos que constituyen las heparinas o las heparinas de bajo peso molecular | |
BR0308506A (pt) | Método para analisar concentrações de moléculas de coenzima a nas amostras biológicas | |
Hesp et al. | Detection of domoic acid in rat serum and brain by direct competitive enzyme-linked immunosorbent assay (cELISA) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: A CLASSIFICACAO ANTERIOR ERA: C08B 37/00 Ipc: C08B 37/00 (2006.01), G01N 30/00 (2006.01) |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 03/11/2015, OBSERVADAS AS CONDICOES LEGAIS. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 16A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2622 DE 06-04-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |